MTRI Mentari Therapeutics, Inc.
$18.60▲ +1.36%
Healthcare
Other
Volume 11.8K
Avg Volume (10D) 42.4K
Key Metrics & Fundamentals
Market Cap
$1.08B
P/E Ratio
–
Div Yield
0.00%
52W Range
5.75 - 23.30
% vs 50 MA
30.77%
% vs 200 MA
51.48%
RSI-14
61.0
MACD Histogram
+0.2200
Beta (1Y vs SPY)
1.07
Free Cash Flow
-$12.33M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$18.54M
COGS
–
Operating Exp
$18.54M
Operating Income
-$18.54M
EBIT
-$18.54M
Pretax Income
-$18.21M
Net Income
-$18.21M
Price & Volume History
Loading chart…
Recent News
Mentari Therapeutics (MTRI) Stock Looks Hard To Pin Down Despite Its 100% 5 Year Fall
Simply Wall St. · Nov 12, 2026 10:14 AM ET
Mentari Therapeutics (MTRI) Shares Just Jumped, So What Is Driving Attention Now?
Simply Wall St. · Nov 12, 2026 12:15 AM ET
Mentari Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire · Nov 9, 2026 8:00 AM ET
Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
GlobeNewswire · Nov 9, 2026 7:00 AM ET
InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics
PR Newswire · Nov 6, 2026 4:05 PM ET
InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI"
TMX Newsfile · Nov 5, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MTRI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.